sonography. A skin incision is usually made along the course of the parietal branch of the STA by using the operative microscope to avoid injuring the artery. Alternatively, a V-shaped incision can be used if both frontal and parietal branches of the STA are planned to be donor vessels, as in the case of a double-barrel STA-MCA bypass. Minor side branches are coagulated and divided sharply. Approximately 1 cm of perivascular and adventitial tissue is sharply dissected from the distal end of the STA branches prior to performing the anastomosis. Both end-to-side or end-to-end anastomosis is possible.
Graft Patency. Graft patency can be achieved in more than 95% of cases with an STA-MCA bypass. 16, 25 According to the International Cooperative Study, the perioperative morbidity and mortality rates were 0.6 and 2.5%, respectively. 12 The advantage of the pedicled graft is that only one anastomosis is required.
Radial Artery Grafts
The RAG is a useful conduit for reconstruction of the ICA in cerebral revascularization. Long-term patency has been demonstrated in the surgical management of giant aneurysms of the cavernous and paraclinoid ICAs. 17 The RA has a lumen that closely approximates that of the M 2 segment and has the advantage of being a physiological conduit for arterial blood. 32 Unlike venous grafts, it lacks valves and varices.
The RA is technically easier to harvest because it has a constant anatomical location and size and is more resistant to kinking than the saphenous vein. 17 The diameter of the RA is 3.55 Ϯ 0.45 mm, which is more compatible with the diameter of the M 2 or P 1 branches. 19 In these cases, RAGs are preferable over high-flow SVGs because flow mismatch can lead to subsequent flow turbulence and graft thrombosis. Because of the valves and the venous endothelium in a vein graft, which may promote thrombosis with low-flow states, RAGs can better tolerate intermittent temporary occlusion in aneurysm dissection.
Graft Extraction. Before harvesting the RAG, an Allen test 2 should be performed. Alternatively, a temporary clip can be placed on the RA intraoperatively while monitoring with a continuous pulse oximeter on the ipsilateral hand. If the oxygen saturation is normal, then the ulnar collateral vessels are sufficient for perfusing the hand.
The artery is exposed at the wrist and traced proximally in the forearm up to the brachial artery bifurcation. The branches of the RA are ligated and/or cauterized. The artery is left in situ until extraction, after which, a small, blunt needle is introduced into the RA. Heparinized saline solution is flushed into the RA until it visibly "pops" and distends. The artery is then plicated over the blunt needle, and the procedure is repeated. A similar process is also performed from the other end of the RA. After spasm of the vessel has been relieved in this manner, the vessel does not spasm again.
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Graft Patency. In 43 patients who underwent RAGinduced ICA reconstruction, Houkin, et al., 17 reported an early patency rate of 95% at 3 weeks postoperatively. In the two cases of acute occlusion, one patient presented with cerebral infarction and permanent neurological deficits, whereas the other patient recovered completely within 1 month. Patients with patent grafts exhibited no ischemic complications or hyperperfusion syndrome after surgery. Regarding long-term patency, there was no delayed occlusion in 20 patients with more than 5 years of follow up. Stenotic changes occurred in two patients; however, there was no sign of reduced CBF or neurological deficit.
Technical Considerations. Radial artery grafting is easier to perform because the vessel wall is thicker. The smooth arterial endothelium can support the slower flow through the vessel with less turbulence. Thus, they are easier to keep open compared with SVGs. In the early experience the major problem with the use of RAGs in cardiovascular bypass was the occurrence of spasm. Fortunately, it was subsequently eliminated after the introduction of the pressure distension technique. 33 One theoretical disadvantage is that these are free arterial grafts. The RA is a muscular artery that relies on a vaso vasorum for its nutrition. Therefore, it was initially postulated that the free RAG would be associated with a higher risk of degenerative change in the arterial wall, producing acute atherosclerotic change and resulting in acute and chronic occlusion of the graft compared with venous conduits. This has been refuted by the data derived from both cardiovascular and cerebrovascular bypass procedures. In the cardiovascular literature, however, the longterm patency rate for pedicled arterial grafts, such as the IMA, is superior to that of RAGs. 11 This may be explained by a significantly greater endothelial production of prostacyclin in the IMA, which counteracts the effects of thromboxane A2 in promoting platelet aggregation and thrombosis. 4, 7 Thus, RAGs, which produce less prostacyclin, have a higher propensity for spasm and rely on antispastic and antiplatelet drugs. 6 The reasons for graft occlusion include problems with the proximal or distal anastomosis, poor endothelium of the donor or recipient arteries, kinking at the proximal or distal anastomotic sites, severe narrowing along the subcutaneous tunnel, significant size disparities between the graft and recipient vessels (resulting in severe turbulence), and spasm of the graft or the recipient artery. Postoperative spasm of the RAGs or the recipient artery can be treated by performing careful intraluminal angioplasty.
Coronary Bypass Data. The technique for RA grafting was first performed in coronary bypass surgery by Carpentier, et al., 5 in 1973. It was thought that the RA was comparable in length and diameter to the IMA, the goldstandard conduit in coronary bypass. The RA is also accustomed to elevated systemic blood pressure, is easily harvested, possesses a thicker arterial wall making it easier to suture, and lacks the valves and varices characteristic of venous grafts. Early postoperative angiography revealed good patency rates. 10 Despite initial promising results, however, there was a high rate of perioperative spasm and occlusion of the bypass conduit, and RAGs for coronary bypass fell out of favor. 10, 14 The development of calcium channel antagonists and improved harvesting techniques led to renewed interest in RAGs and restored their place in cardiovascular practice. 1, 18 With recent advances, the long-term patency rate associated with RAGs in patients undergoing myocardial revascularization has improved dramatically, with a 5-year patency rate of greater than 90%. 26 Although the IMA remains the preferred conduit for arterial myocardial revascularization, the RA is an excellent alternative conduit that offering good long-term clinical and angiographic results.
Interposition SVG
Saphenous vein grafts have been widely used in both coronary and peripheral vascular surgery. The saphenous vein is readily accessible from the lower leg and/or thigh and can be tailored to varying lengths. Greater SVG bypasses created between the extracranial and intracranial circulation were originally performed to provide acute high-volume collateral flow to the cerebral circulation in patients with impending cerebral infarction due to cerebroocclusive disease. 22 More recently, SVGs have often been used in the treatment of giant aneurysms or skull base tumors when acute sacrifice of the ICA is necessary. 9, 24, 30, 31, 33, [35] [36] [37] Graft Extraction. The thigh is abducted and externally rotated. An incision is made from the groin crease just medial to the femoral pulse toward the medial condyle of the femur. Once the vein is identified, it is followed cranially by the saphenofemoral junction. A 10 to 25-cm length of the vessel is exposed, depending on the length of interposition graft needed. Papaverine (3 mg/ml) is injected into the adventitia. After the vein is harvested, the graft is flushed and irrigated with heparinized saline solution for a minimum period of time prior to anastomosis.
Graft Patency. In a review of 202 long SVGs for cerebrovascular bypass performed at the Mayo Clinic by Regli, et al.,28 14% were occluded within 30 days of surgery. Of these, 62% were occluded within the 1st day of surgery. Unfortunately, 72% of patients with early graft occlusion suffered neurological deterioration, including massive cerebral infarction with profound deficits. Late graft failures (Ͼ 12 months from the initial surgery) occurred in 8%. The cumulative patency was 86% at 1 year, 82% at 5 years, and 73% at 13 years, with a mean annual graft failure rate of 1 to 1.5% after the 1st year. In contrast to early occlusion, 80% of patients with a late graft occlusion remained asymptomatic. The cumulative 5-year survival rate was 78% in patients with a patent graft compared with 49% in those with an occluded graft.
Graft occlusion did not correlate with sex, cerebral vascular territory, primary cerebrovascular disease, or underlying vascular risk factors such as smoking, hypertension, coronary artery disease, or diabetes mellitus. Of the grafts in which blood flow was less than 50 ml/minute, however, 36% became occluded compared with 13% in which the flow was between 50 and 200 ml/minute (p Ͻ 0.05). 28 Smaller-diameter veins of less than 6 mm had higher rates of occlusion. Vein grafts anastomosed to a larger trunk had a higher patency rate compared with those surgically attached to small branch of the posterior cerebral artery or MCA. These results are supported by Poiseuille's law; substantial flow is required to maintain graft patency. This phenomenon is also observed in SVG-established coronary bypass in which patency has been demonstrated to increase with flows rates greater than 40 ml/minute and runoff vessel diameters greater than 1.5 mm. 15, 29 Technical Considerations. Early graft occlusion is due to thrombosis and fibrous intimal proliferation, probably as a result of early platelet deposition on the vein graft. This process is accelerated by turbulent blood flow and is most prominent at the site of the distal anastomosis. Late occlusion of the graft is mostly caused by the development of atherosclerosis in the vein grafts. Most of these occlusions are related to intraoperative technique. The surgeon should be mindful of endothelial damage of the vein graft, graft blood flow, and blood coagulability. 38 Mechanical trauma inflicted on the vein may occur during harvesting and vein preparation or when sheer stress is placed on the vein transplanted to an arterial system. To reduce surgical manipulation, the vein is left in situ and covered with papaverine until transposition. To reduce the chance of acute thrombosis, patients are started on antiplatelet agents prior to surgery, undergo heparinization prior to temporary occlusion, and receive permanent antiplatelet therapy postoperatively.
The proximal and distal anastomoses should be reconstructed so that an adequate pressure head and minimal turbulence are provided. The shortest possible length of the vein graft, and end-to-end anastomosis at both ends of the graft are preferred to reduce turbulent flow. 35 A major trunk, such as the supraclinoid ICA or MCA, should be the recipient vessel to ensure adequate runoff for the highflow SVG bypass.
Coronary Bypass Data. Traditionally, venous conduits, particularly the greater saphenous vein, are used as a conduit for coronary artery bypass. The 1-year patency rates for the aortocoronary greater SVGs are between 80 and 90%. 23 In coronary bypass surgery, occlusion of vein grafts increases over time with thrombosis occurring in greater than 60% of aortocoronary grafts at 10 years postoperatively. 3, 8 Similar to cerebrovascular bypass experiences, early graft patency is thought to be related to operative technique, whereas late graft patency is related to the development of graft atherosclerosis. In prior studies, 50% of aortocoronary vein grafts had closed postoperatively at 10 years. Of those that remained patent, approximately 50% showed wall alterations consistent with vein graft atherosclerosis. There is a steep drop (10-20%) in patency during the 1st year after surgery. Thereafter the occlusion rate is 2 to 4% in the first 5 years, doubling to 4 to 8% annually after the 5th year. 27 In contrast, despite a similar early marked drop in the patency rate, the occlusion rate of SVGs in cerebral revascularization remained stable at 1 to 1.5% per year after the 1st year.
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CONCLUSIONS
Choosing the appropriate conduit in bypass surgery is critical for successful cerebral revascularization. If the STA is unavailable or a higher-flow bypass is desired, interpositional conduits, such as the RA and saphenous vein, should be used. Meticulous technique in graft harvesting and microsurgical anastomosis is required for optimal graft patency.
